Novartis AG is 56.4x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($282.64 B vs $5.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | XENE | NVS |
|---|---|---|
| Market cap | $5.01 B | $282.64 B |
| US-listed rank | #1389 | #47 |
| Revenue (latest FY) | $7.50M | - |
| Net income (latest FY) | -$345.91M | - |
| Net margin | -4612.1% | - |
| SEC filings | 763 | 947 |
Novartis AG is 56.4x more valuable than Xenon Pharmaceuticals Inc. by market capitalization ($282.64 B vs $5.01 B).
Full pages: Xenon Pharmaceuticals Inc. and Novartis AG, or browse the full rankings.